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Abstract
Background: The Chronic Sinusitis Survey (CSS) is a valid, disease-specific questionnaire for
assessing health status and treatment effectiveness in chronic rhinosinusitis. In the present study,
we developed a Norwegian version of the CSS and assessed its psychometric properties.
Methods: In the pooled data set of 65 patients from a trial of treatment for chronic sinusitis with
long-standing symptoms and signs of sinusitis on computed tomography (CT), we assessed the
reliability, validity and responsiveness of the CSS.
Results: Test-retest reliability of the two CSS scales and the total scale ranged 0.87–0.92, while
internal consistency reliability ranged 0.31–0.55. CSS subscale scores were associated with other
items on sinusitis symptoms, and with the Mental health and Bodily pain scale of the SF-36. There
was little association of the CSS scale scores with sinus CT findings. The patients with chronic
sinusitis had worse scores on all three CSS scales than a healthy reference population (n = 42) (p
< 0.001). The CSS sinus symptoms subscale and the total scale were sensitive to improvement in
global symptoms during 12 weeks.
Conclusion: The Norwegian version of the CSS had acceptable test-retest reliability, but lower
internal consistency reliability than the accepted standard criteria. The results support the
construct validity of the measure and the sinusitis symptoms subscale and the total scales were
responsive to change. This supports the use of the questionnaire in interventions for chronic
sinusitis, but points at problems with the internal consistency reliability.
Background
Sinusitis is a common condition that causes frequent phy-
sician visits. In the United States in 1999–2000, chronic
sinusitis was accountable for more than 13 million ambu-
latory care visits, or 1.3 % of all visits [1]. The symptoms
of chronic sinusitis are not easy to quantify [2] and show
little association with computed tomography (CT) find-
ings [3]. Postoperatively, imaging is also unreliable
because of postoperative changes and scarring [4].
Health-related quality of life (HRQoL) has recently gained
increased awareness as an outcome measure for interven-
tions in chronic sinusitis [2,5-11]. Some studies of inter-
ventions in chronic sinusitis have used generic HRQoL
measures, which are developed for use in a wide range of
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tional and social health or functioning, such as the Short
Form 36 (SF-36) [12]. To increase the sensitivity to
change, disease-specific measures have been developed to
assess the impairment of chronic sinusitis and the effects
of interventions. A review reported that only three instru-
ment for outcome in chronic sinusitis had acceptable per-
formance characteristics with documented reliability,
validity and responsiveness [5,13-15], however new
instruments have later been introduced [16].
The Chronic Sinusitis Survey (CSS) is a valid, disease-spe-
cific questionnaire for assessing health status and treat-
ment effectiveness in chronic rhinosinusitis [2,5,10]. In
the present study, we developed a Norwegian version of
the CSS and assessed its psychometric properties in the
pooled sample of patients in an intervention for chronic
sinusitis [17].
Methods
Subjects and study design
We included patients above 17 years of age with sinusitis
symptoms for more than three months and sinus swell-
ing, fluid retention, or opacification on CT. Patients with
polypous sinusitis or pansinusitis, pregnancy, previous
acupuncture treatment, previous surgery for chronic
sinusitis, or recent medication use that could influence
the results of the study were excluded [17]. We evaluated
more than 500 patients with sinusitis for eligibility to the
study. In total, 65 patients were included from August
1996 to December 2000. Patients were initially recruited
from the clinical practice of one otorhino-laryngologist
and later also through advertising in local newspapers and
a magazine.
One otorhino-laryngologist examined and included all
patients. He allocated them to one of three groups accord-
ing to a six-block randomisation algorithm. The major
reasons for exclusion estimated post hoc by the otorhino-
laryngologist were: normal CT (30%), heavy allergies
(20%), refused conventional medical therapy (10%),
trigeminal neuralgia (10%) and did not want a CT-scan
(5%).
The patients had one of three treatments: conventional
medical therapy with antibiotics and local congestants,
traditional Chinese acupuncture, or minimal acupuncture
at non-acupoints. No treatments were given during the
Norwegian allergy season (February – September),
because some of the patients were expected to have sea-
sonal allergies [17]. For the purpose of this validation
study, we pooled the three study arms in the analysis.
Health status assessment
We assessed HRQoL at baseline, after 12 weeks and 13
weeks with several instruments. The purpose of the 13-
week assessment was to assess test-retest reliability of the
questionnaires, by comparison with the 12-week assess-
ment.
Chronic sinusitis survey (CSS)
The CSS is a 6-item duration-based, sinus-specific ques-
tionnaire with a symptom and a medication subscale. It is
developed at the Massachusetts Eye and Ear Infirmary
[2,5,10] and also exists in Chinese and Turkish versions
[18,19]. We obtained permission to use the CSS and trans-
lated the questionnaire to Norwegian according to a rec-
ommended procedure [20]. First, two individuals
translated the CSS into Norwegian independently. They
then met and discussed with a third person, agreeing on a
consensus version. Later, this consensus version was back-
translated into English by an American fluent in Norwe-
gian. Comparison of the backtranslation with the original
English version revealed little discrepancies, and the ques-
tionnaires were considered conceptually and linguistically
equivalent. The Norwegian version of the CSS is enclosed
' [see Additional file 1]'.
Short Form 36 (SF-36)
The general health status questionnaire SF-36 assesses
eight dimensions of health status including physical func-
tioning, role limitations due to physical problems, bodily
pain, general health, vitality, social functioning, role lim-
itations due to emotional problems and mental health
[12,21]. The scales were scored from 0 (lowest level of
functioning) to 100 (highest level of functioning). The SF-
36 has been extensively validated in general populations
[12,21], and in many diseases including subjects with
chronic rhinosinusitis [9,10,15,22]. We used the Norwe-
gian standard SF-36 version 1.2 [23]. Additionally, we
scored the physical component summary (PCS) and men-
tal component summary (MCS) scales [24]. These two
scales were scored and transformed for comparison with a
U.S. general population with mean 50 and SD 10.
Sinus computed tomography
At baseline and 4–6 weeks later the patients had sinus CT
scans. An otorhino-laryngologist assessed soft tissue
swelling in millimetres and signs of fluid retention and
opacification on the CT-scans [17].
Sinusitis symptom assessment
The patients reported on six symptoms of chronic sinusitis
using a self-administered questionnaire [17]: (1) mucus
production, (2) maxillary headache, (3) stuffed nose, (4)
frontal headache, (5) ability to smell, and (5) feeling of
illness. The first four items were scored on an ordinal scale
with the response alternatives none, little, some, much,Page 2 of 9
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had the response alternatives none, little, some, close to
normal, normal (recoded on a 4-0 scale). The sixth item
had the response alternatives very ill, ill, a little ill, healthy
(recoded 3-0). The recoded six symptom scores were
summed to give an aggregate value representing a "sinusi-
tis symptom score", with a score ranging from 0 (minimal
symptoms) to 23 (maximal symptoms) [17].
Healthy comparison group
To have a healthy comparison group, with which we
could compare the CSS scores, we used a convenience
sample of hospital personnel (n = 42). These subjects only
responded to the CSS and items on age and sex.
Statistical analysis
Descriptive statistics are presented with means and SDs, or
percentages. Group characteristics were compared using
the t-test or χ2 test.
Internal consistency reliability of the scales was assessed
using Cronbach's α [25]. Test-retest reliability of the
aggregate scales was assessed with an intraclass correlation
coefficient (ICC), using the average of raters in a two-way
mixed model with an absolute agreement definition. To
minimize the subjects' recall for the previous answers, the
test-retest was done using individual patient scores 12 and
13 weeks after randomization. We excluded assessments
more than 21 days apart. The time between the assess-
ments was median 7 days (range 6 to 21).
Construct validity of the scales of the CSS was assessed by
correlations with: (1) corresponding items of the SF-36,
and (2) the items on the sinusitis symptom scale. We used
Spearman's rank correlations because of the ordinal scale
on sinusitis symptoms items. A finding of higher correla-
tions between items measuring related phenomena than
between non-corresponding items would support con-
struct validity.
The discriminant validity of the CSS and the SF-36 was
evaluated by the capacity of the subscales to differentiate
between two groups with expected differences in health
status. For this purpose, we used grading of CT sinus soft
tissue swelling (sum of six measures of sinus soft tissue
swelling) in millimeters, dividing the patients into two
groups according to score below or above the median of
12 mm. In this comparison, we adjusted for age using
analysis of variance. We similarly compared scores
between two groups divided according to the median of
the overall symptom score (≤ 9 vs. >9).
Finally, we compared CSS scores in the total sample of
patients with chronic sinusitis with the healthy compari-
son group of hospital personnel, using the t-test for inde-
pendent samples.
Responsiveness was assessed in the pooled sample using
change in the overall symptom score as an indicator of
global change. The SD of the baseline overall symptom
score was 3.1. We used a change of 2 units on the (equiv-
alent to 0.65 SD) to denote a meaningful change. We had
no empirical evidence for this, however previous reports
have suggested that minimally clinical important changes
frequently are about 0.5 SD [26], hence our choice is in
accordance with this. We report responsiveness as stand-
ardized response mean (SRM) (mean change/SD of
change) and effect size (mean change/SD at baseline)
[27]. Because patients in one of the treatment arms were
given antibiotics and other medication as part of the pro-
tocol, we excluded patients in this treatment arm from the
analysis of responsiveness of the CSS Medication usage
and Total scales. These scales are influenced directly by
medication use. Instead, we would expect this group to
report deterioration in score on the CSS Medication usage
subscale.
We chose a significance level of 5%. For statistical analy-
sis, we used Stata version 8.2 (Stata Corp., College Station,
TX) and SPSS version 12.0 (SPSS Inc, Chicago, IL). The
Regional Committee for Medical Research Ethics and The
Norwegian Data Inspectorate approved the study.
Table 1: Baseline subject characteristics, mean (SD)
Chronic sinusitis Healthy controls p
N 65 42
Women, number (%) 33 (51) 25 (60) 0.38
Age (years) 43.0 (13.8) 42.8 (12.1) 0.95
Duration of chronic sinusitis 
(years)
9.5 (10.7) - -
Known allergy, number (%) 12 (19) - -
Current smokers, number (%) 23 (35) - -
Sinus soft tissue swelling in mm* 13.3 (10.6) - -
*Sum of 2 maxillary, 2 frontal, ethmoidal and sphenoidal soft tissue swelling measurements, n = 64Page 3 of 9
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The mean age of the participants was 43 years, 51% were
women and 35% were current smokers. On baseline sinus
CT, 17 patients had opacification, 2 had fluid retention,
and 57 had sinus soft tissue swelling. There was no differ-
ence in age or sex between the chronic sinusitis group and
the healthy comparison group (table 1).
Completers, who responded to the sinusitis symptoms
scale of the CSS at baseline and after 12 weeks (n = 47),
tended to be somewhat older, had suffered from chronic
sinusitis longer, and had better baseline CSS and SF-36
scores on all subscales than dropouts (n = 18) after 12
weeks, although only the differences on the General
health (p = 0.03) and the Social functioning scales (p =
0.04) of the SF-36 were statistically significant.
At baseline the mean CSS sinus symptoms score was 40
(SD 26) and the medication usage score 83 (SD 18) (table
2). On the sinus symptoms scale, 13% of respondents
scored the lowest possible value and on the medication
usage scale 32% of respondents scored the highest possi-
ble value, the latter indicting an apparent ceiling effect.
On the SF-36 scales, there were signs of a floor effect on
the Role-physical and Role-emotional scales, and ceiling
effects on the Physical functioning, Role-physical, Bodily
pain, Social functioning and Role-emotional scales (table
2).
Internal consistency relibility, as assessed with Cronbach's
α, ranged 0.31 to 0.55 for the CSS scales and 0.72 to 0.91
for the eight SF-36 scales (table 2). Test retest reliability
ranged 0.87 to 0.94 for the CSS scales and 0.76 to 0.94 for
the SF-36 scales (table 2).
The multitrait-multimethod matrix showed that the corre-
lations between the CSS Sinus symptoms subscale had the
highest correlations with other symptom items or scales,
such as those on mucus production (-0.38), stuffed nose
(-0.45), general feeling of illness (-0.43) and the aggre-
gated sum of symptoms score (-0.45) and the SF-36 scale
Bodily Pain (0.36) (table 3). In contrast there was little
association of the medication usage scale with the SF-36
scales and the symptom items. The CSS total scale, which
represents an average of the two subscales, showed high
correlation with the Role-emotional scale of the SF-36
(0.73) and moderate correlation with the Bodily pain
scale (0.41) of the SF-36 and the feeling of illness item (-
0.44) and Sum of symptoms scale (-0.41).
The CSS and SF-36 scales were not able to discriminate
between the group of patients with aggregate sinus soft tis-
sue swelling ≤ 12 mm versus >12 mm (table 4). In con-
trast, the CSS sinus symptom and total scales, and the SF-
36 Bodily Pain and Mental health scales discriminated
between patients divided into groups according to overall
symptom scale score above or below the median (table 4).
When comparing CSS scores in the total sample of
patients with chronic sinusitis with the healthy compari-
son group, there was a marked difference in scores on the
two subscales and the total score (table 5).
Of the 47 patients that completed the study, 22 reported
improved overall symptom score (change < -2 units), 19
were unchanged (change of -2 to 2 units), and 6 were
Table 2: Baseline health-related quality of life scores and reliability assessments
N Number of items Range Mean (SD) %Floor %Ceiling Internal consistency 
reliability*
Test-retest 
reliability**
Chronic sinusitis survey (0–100 scale)
Sinus symptoms 63 3 0–100 40 (26) 13 2 0.55 0.92
Medication usage 62 3 17–100 83 (18) 0 32 0.31 0.87
Total 61 6 29–92 62 (16) 0 0 0.39 0.94
SF-36 (0–100 scale)
Physical functioning 63 10 10–100 82 (20) 0 16 0.91 0.93
Role – physical 64 4 0–100 54 (41) 25 33 0.83 0.86
Bodily pain 64 2 0–100 60 (23) 2 13 0.86 0.88
General health 64 5 15–100 59 (23) 2 2 0.76 0.94
Vitality 64 4 0–85 47 (23) 5 0 0.87 0.90
Social functioning 64 2 13–100 69 (26) 0 23 0.81 0.84
Role – emotional 62 3 0–100 66 (38) 16 45 0.72 0.76
Mental health 64 5 16–100 74 (17) 0 2 0.82 0.89
Physical component summary*** 61 35 21–61 44 (9) - - - 0.94
Mental component summary*** 61 35 23–59 46 (11) - - - 0.90
%Floor = percentage of patients scoring lowest possible value, %Ceiling = percentage of patients scoring highest possible value.
* Cronbach's alpha, ** Intraclass correlation coefficient, N = 38–41, *** Standardized for comparison with an American general population with 
mean 50, SD 10.Page 4 of 9
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too small for further analysis. The responsiveness indices
in general were larger in the improved group than in the
unchanged group and in the right direction for all indices
Table 3: Spearman's rank correlation coefficients between baseline scores on scales of the Chronic sinusitis survey, SF-36, and items of 
a sinusitis symptoms scale (n = 60–63)
Chronic sinusitis survey scale
Sinus symptoms Medication usage Total
SF-36 scale
Physical functioning -0.13 0.17 -0.02
Role – physical -0.16 0.1 0.2
Bodily pain 0.36* 0.15 0.41**
General health -0.08 0.14 0.03
Vitality 0.08 -0.07 0.01
Social functioning 0.05 0.1 0.12
Role – emotional 0.08 -0.04 0.73
Mental health 0.21 -0.03 0.17
Physical component summary 0.08 0.19 0.19
Mental component summary 0.10 -0.06 0.08
Sinusitis symptoms
Mucus production -0.38** 0.18 -0.25
Stuffed nose -0.45** 0.14 -0.29*
Frontal headache -0.32** 0.04 -0.26*
Maxillary headache -0.11 -0.1 -0.19
Ability to smell 0.02 -0.13 -0.09
Feeling of illness -0.43** -0.08 -0.44**
Sum of symptoms -0.45** -0.02 -0.41**
* ≤ 0.05, ** ≤ 0.01
Table 4: Age-adjusted quality of life scores according to baseline CT scores among those with sinus soft tissue swelling (n = 45) and 
overall symptom score (groups defined with the median as cut-off), mean (SE)
CT soft tissue swelling Overall symptom score
None ≤ 12 mm >12 mm p* ≤ 9 >9 p
n 10 23 22 37–39 24
Chronic sinusitis 
survey (0–100 
scale)
Sinus symptoms 49 (9) 40 (6) 38 (5) 0.80 48 (4) 28 (5) 0.005
Medication 
usage
82 (6) 84 (4) 83 (3) 0.86 84 (3) 82 (4) 0.71
Total 65 (5) 63 (4) 60 (3) 0.56 66 (3) 55 (3) 0.01
Short Form 36 
(0–100 scale)
Physical 
functioning
81 (7) 84 (4) 82 (4) 0.70 85 (3) 78 (4) 0.16
Role – physical 61 (13) 47 (9) 56 (7) 0.42 57 (6) 48 (8) 0.43
Bodily pain 58 (7) 63 (5) 57 (4) 0.34 66 (3) 48 (4) 0.002
General health 61 (7) 61 (5) 56 (4) 0.50 58 (4) 59 (5) 0.83
Vitality 52 (7) 47 (5) 46 (4) 0.87 49 (4) 45 (5) 0.50
Social 
functioning
69 (8) 71 (6) 68 (5) 0.68 72 (4) 65 (5) 0.28
Role – 
emotional
69 (12) 71 (8) 60 (7) 0.31 70 (6) 58 (8) 0.28
Mental health 73 (5) 77 (4) 72 (3) 0.29 77 (3) 69 (3) 0.05
PCS 45 (3) 43 (2) 44 (2) 0.81 45 (2) 42 (2) 0.22
MCS 46 (4) 48 (2) 45 (2) 0.33 47 (2) 44 (2) 0.28
* comparison of ≤ 12 mm group vs. >12 mmPage 5 of 9
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(SRM of 0.66–1.03, ES 0.69 to 1.29) and the SF-36 scales
Bodily pain, Social functioning, and Physical component
summary (SRM 0.65–0.84; ES 0.65 to 0.79) were the
scales most responsive to improvement (table 6). The
medication usage scale showed little sensitivity to change.
In the conventional group with medication as part of the
intervention, the unchanged symptom group reported
SRM and ES of -0.29 (n = 4). In the improved group SRM
was -0.40 and ES -0.64 (n = 10), in accordance with
increased use of medication during the study than before.
Discussion
In this study we have documented translation of the CSS
into Norwegian and assessed aspects of its reliability,
validity and responsiveness in patients with CT-verified
chronic sinusitis. The internal consistency reliability of the
Table 5: Chronic sinusitis survey scores (0–100 scale) for patients with chronicsinusitis compared with a healthy reference population, 
mean (SD)
Chronic sinusitis Healthy controls p
n 61–63 42
Sinus symptoms 40 (26) 87 (19) <0.001
Medication usage 83 (18) 98 (6) <0.001
Total 61 (16) 92 (11) <0.001
Table 6: Change in quality of life scores according to changes in overall symptom score from baseline to week 12
Unchanged Improved
N Mean
change 0
to 12
weeks
SD of
change
within
group
SRM Effect size N Mean
change 0
to 12
weeks
SD of
change
within
group
SRM Effect size
Chronic 
sinusitis 
survey
Sinus 
symptoms
18 2 25 0.09 0.08 20 33 32 1.02 1.29
Medication 
usage*
15 2 22 0.08 0.08 11 5 24 0.20 0.25
Total* 15 5 15 0.31 0.28 10 13 21 0.66 0.69
Short Form 
36
Physical 
functioning
19 -2 9 -0.17 -0.11 22 10 20 0.49 0.39
Role – 
physical
19 -3 33 -0.08 -0.07 22 20 42 0.47 0.51
Bodily pain 19 3 16 0.16 0.10 22 16 25 0.65 0.74
General 
health
19 -5 14 -0.38 -0.23 22 12 21 0.55 0.47
Vitality 19 5 15 0.31 0.22 22 9 26 0.33 0.36
Social 
functioning
19 1 16 0.08 0.06 22 17 20 0.84 0.65
Role – 
emotional
19 4 27 0.13 0.12 22 9 37 0.24 0.24
Mental 
health
19 -0.3 15 -0.02 -0.02 22 5 17 0.28 0.23
Physical 
componen
t summary
19 -1 5 -0.18 -0.12 22 6 9 0.74 0.79
Mental 
componen
t summary
19 1 6 0.23 0.18 22 3 11 0.28 0.25
SRM = standardized response mean; *patients receiving conventional medical treatment with medication were excluded from this analysis (n = 14).Page 6 of 9
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of 0.70 usually considered acceptable for group use [28].
The internal consistency reliability in the present study
was lower than previously reported for the CSS scales in
some studies [5,18], for some scales of the RhinoQOL
[6,16] and some other instruments [14,15,29,30]. How-
ever, the internal consistency reliability was at the level of
the CSS in another study [6] and some other RhinoQOL
scales [6,18]. In contrast all, eight SF-36 scales in the
present study had internal consistency reliability <0.70.
The problems with internal consistency of the CSS could
be related to the low number of CSS items, as internal
consistency normally increases with increasing number of
items. Hence, there is a trade-off between ease of admin-
istration and internal consistency.
The test-retest reliability in the present study was substan-
tial for all CSS and SF-36 scales, as previously reported for
the CSS [5,18] and higher than reported for some other
disease-specific instruments [6,29]. However, these com-
parisons should be interpreted carefully, because of differ-
ences in samples and assessment methods.
Assessment of cross-sectional validity in the present study
showed that the CSS total scale was moderately associated
with the Bodily pain scale of the SF-36, at the level previ-
ously reported [5]. The association of the CSS total with
the Role-emotional scale of the SF-36 was higher than pre-
viously reported [5]. Further, there was marked difference
between CSS subscale and total scores among patients
with chronic sinusitis and the healthy comparison group.
These findings and the associations with symptom scores
were in line with expectations and give support to con-
struct validity of the CSS [31]. In contrast, when relating
the CSS and SF-36 scale scores to the CT findings, there
was little association. This finding supports previous find-
ings that there is little association between symptoms and
CT based severity staging in chronic sinusitis [32-34]. The
results from the comparison of CSS scores with healthy
controls in the present study are in line with previous sim-
ilar comparisons with general population values [2,35].
Some subscales of both the CSS and the SF-36 were sensi-
tive to change in this pooled sample of patients receiving
three different interventions, in accordance with previous
reports of surgical interventions [2,6,10] The ES for the
responsive scales ranged from medium to large, using the
nomenclature of Cohen, where an ES of 0.2 is considered
small, 0.5 medium, and 0.8 represents a large ES [36]. In
the present study, the sinusitis symptoms subscale of the
CSS was more responsive than the medication use sub-
scale, as previously reported [6]. The medication use sub-
scale of the CSS is not feasible for use with interventions
using pharmaceuticals, as in one of the arms of the present
study; however, we think this subscale is more justified in
surgical interventions.
Compared with other disease-specific questionnaires for
use in chronic sinusitis, the CSS is short, easy to use, has
documented validity, and scores are available for healthy
populations. In the present study, we did not compare the
questionnaire with other disease-specific instruments.
However, we think the CSS is a feasible disease-specific
instrument for use in many interventions, and more doc-
umentation exists for this instrument than for other sinus-
specific HRQoL instruments.
Some weaknesses of our study should be mentioned. The
sample size was small, hence reducing the power of the
study. Periodicity or seasonality of symptoms or environ-
mental factors might influence our measured outcomes.
In lack of a gold standard, we compared scores in chronic
sinusitis with those in a healthy convenience sample and
assessed cross-sectional associations with CT findings and
a symptom score that we had developed for this study.
However, this scale has not been subject to the same rig-
orous testing as the HRQoL measures. We based its use in
the present study on an assumption of face validity of the
items. We also did not use a standardized and validated
CT staging system, but the lack of association with our sys-
tem was in accordance with previous reports [32-34].
Responsiveness was assessed using change in overall
symptoms as benchmark, which we thought was the best
estimate of global outcome that we could find.
Because we only included patients with CT-verified sinusi-
tis, we included a small proportion of all patients present-
ing symptoms of chronic sinusitis. Hence, one should be
careful extrapolating the results of the study beyond
patients with CT-verified sinus soft tissue swelling.
Conclusion
We have documented the translation of the CSS into Nor-
wegian and shown that this version of the CSS had sub-
stantial test-retest reliability, but there were problems with
the internal consistency reliability. This suggests that the
two three-point scales were not homogeneous. The cross-
sectional associations give support to validity of the scales
in chronic sinusitis. Finally, scales of the CSS and the SF-
36 were responsive in this pooled population receiving
three different interventions.
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